The influence of health systems on breast, cervical and colorectal cancer screening: an overview of systematic reviews using health systems and implementation research frameworks by Priaulx, J. (Jennifer) et al.
Review Article
The influence of health systems on
breast, cervical and colorectal cancer
screening: an overview of systematic
reviews using health systems and
implementation research frameworks
Jennifer Priaulx1 , Eleanor Turnbull1, Eveline Heijnsdijk2,
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Abstract
Objectives: Screening for breast, cervical and colorectal cancer in an average-risk population is widely recommended
in national and international guidelines although their implementation varies. Using a conceptual framework that draws
on implementation and health systems research, we provide an overview of systematic literature reviews that address
health system and service barriers or facilitators to effective cancer screening.
Methods: Using a systematic approach, we searched Cochrane Database of Systematic Reviews, Ovid Medline,
Ovid Embase, Web of Science, PsychInfo and other internet sources. We included systematic reviews of screening
interventions (i.e. targeting people at average risk) for breast, cervical and colorectal cancer. The analysis included
90 systematic reviews.
Results: This review identified a multitude of barriers and facilitators affecting the health system, the capabilities of
individuals in the system and their intentions. A large proportion of the available evidence focused on uptake.
The reviews demonstrated that health system factors influenced participation, as well as quality and effectiveness of
the service provided. The barriers with the biggest impact were knowledge/education, mainly of clients but also
providers (capability barriers) and beliefs and values (intention barriers) of the eligible population. These findings com-
plement the usual focus on psychological and social barriers to informed participation by individuals that dominate the
screening literature. The facilitators with the most supporting evidence were educational interventions (overcoming
capability and intention barriers), invitation letters, reminders and appointments. These were mainly directed at eligible
individuals and, to a lesser extent, to providers and healthcare professionals. Only a small number of reviews, mainly
from Europe, specified organized, rather than opportunistic, screening programmes. In those, low participation was the
most frequently cited barrier and invitation letters (including physician endorsement, phone calls and reminders to non-
responders and healthcare professionals) were the most prevalent facilitators.
Conclusion: Despite evidence of barriers and facilitators to screening participation and opportunistic screening,
further health systems research covering the entire screening system for organized programmes is required.
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The European Union recommends population-based
screening programmes for breast, cervical and colorectal
cancer,1 while various guidelines set out how to implement
such programmes.2–6 However, implementation varies
greatly,7 and many programmes fall short of the ideal.8,9
While much research examines the characteristics of indi-
viduals undergoing screening, there is, to our knowledge,
much less focus on the characteristics of health systems
that support or inhibit effective screening programmes.
In this article, we report the findings from an umbrel-
la review of existing systematic reviews seeking to iden-
tify barriers and facilitators to population-based
screening that are related to characteristics of health
systems. We use the World Health Organization’s
(WHO) definition of health systems as consisting of
‘all organizations, people and actions whose primary
intent is to promote, restore or maintain health’.10
First, we identify barriers that have been reported in
the literature and, where possible, assess their impact.
Second, we identify measures that have been suggested
to overcome these barriers and, where possible, assess
their effectiveness. Third, we seek to understand the
influence that these barriers and facilitators have on
organized screening programmes. We use frameworks11
that draw on theories from behaviour change12 and
implementation research,13 including those used by
Michie et al.14 who propose 12 subthemes for investigat-
ing implementation of evidence-based practice, orga-
nized within three main themes. Health system barriers
include availability of resources, affordability and
acceptability of health services. Capability barriers
relate to knowledge or skills to implement effective
screening programmes. Intention barriers relate to moti-
vations of providers to achieve effective screening. When
looking at health systems barriers, we draw on two relat-
ed frameworks. The first was used in previous systematic
reviews of barriers and facilitators to effective hyperten-
sion management11,15 and considers the contribution of
health system inputs, including physical, human, intel-
lectual and social resources, on outcomes. The second is
the WHO’s health systems building blocks, with service
delivery, the health workforce, health information sys-
tems, leadership and governance and financing most rel-
evant to screening.16 However, in practice, many of the
barriers we identify involve a combination of elements,
for example, where locations are underserved by facili-
ties, it reflects both weaknesses in service delivery and
inability to recruit and retain staff.
Objectives
We reviewed systematic literature reviews that identify,
explore and evaluate barriers and facilitators to
establishing effective cancer screening programmes at
health system and health service level. We sought to
identify gaps and make recommendations for future
research. Individual cultural, psychological and social
obstacles to informed participation lay outside the
scope of this review.
Methods
A protocol was registered ‘a priori’ on PROSPERO,
the international prospective register of systemat-
ic reviews.17
Search strategy and selection
We searched for relevant systematic reviews in the fol-
lowing databases: Cochrane Database of Systematic
Reviews; Ovid Medline; Ovid Embase; Web of
Science; PsychInfo and Google Scholar. We reviewed
project websites (for example, Evidence for Policy and
Practice Information Centre; Health Systems Evidence;
Health Evidence Network; Agency for Healthcare
Research and Quality) and contacted experts partici-
pating in the EU-TOPIA (TOwards imProved screen-
ing for breast, cervical and colorectal cancer In All of
Europe) project,18 of which this research forms a part,
to identify relevant grey literature. Reference lists of
publications retrieved were manually searched.
Selected databases were searched from 1st January
2000 to 9th June 2017 using relevant search terms
(Appendix 1, online supplement). Two reviewers inde-
pendently assessed the titles and abstracts of the iden-
tified publications according to predefined inclusion
criteria (Appendix 2, online supplement), and differen-
ces were resolved by discussion.
Data collection and analysis
Data from included systematic reviews were extracted
using a predefined data extraction sheet. Fields includ-
ed: authors; year of publication; objectives; selection
criteria; information about barriers and facilitators
and impact on the effectiveness of screening. Authors
were contacted where full texts were not available (only
one responded). Data were extracted by one reviewer
and checked by a second reviewer who extracted
data on study design and applied the AMSTAR
(A MeaSurement Tool to Assess systematic Reviews).
Reviews were not excluded from data extraction on
grounds of quality.
A narrative synthesis using the conceptual frame-
work (Figure 1) was conducted. The heterogeneous
nature of the included data precluded quantitative syn-
thesis or formal assessment of publication bias.
We collated the data for all cancer sites together but
noted where items were relevant to only one cancer site.
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We analysed differences between organized screening
programmes and other screening interventions.
Results
Study characteristics and quality
From 536 identified titles, 90 articles were included in
the review (Figure 2). As summarized in Table 1, of the
90 included articles, 75 were in English, and 15 had
abstracts available in English. A summary of the char-
acteristics of the included systematic reviews is presented
in Appendix 3 (online supplement), and a list of exclud-
ed reviews is reported in Appendix 4 (online supple-
ment). A summary of the quality of the included
systematic reviews, assessed using the AMSTAR instru-
ment, is presented in supporting information Appendix
5 (online supplement). Whilst generally of good quality,
included reviews used slightly different reporting criteria
to those in the AMSTAR checklist, for quantitative
meta-analysis studies and controlled trials.
Drawing on the first conceptual framework, as
shown in Figure 3, we found that whilst health
system resources, financing and delivery were men-
tioned in some included systematic reviews, the vast
majority were interested in ‘other factors’ that acted
as barriers or facilitators to screening, most notably
the target population’s health knowledge, the effective-
ness of appointment reminders, personal and cultural
beliefs and physician recommendations.
In the following sections, the second framework
allows us to describe the barriers and ways to overcome
those barriers in more detail using the health system,
capability and intention categories and their subcate-
gories, described in Figure 4.
Figure 1. Health systems conceptual framework for barriers and facilitators to effective cancer screening.11,12,14,15
Figure 2. Flow diagram of study selection process.
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Barriers to effective screening
Health system barriers. Much of the literature addresses
barriers that reduce uptake of screening. These can be
geographical, temporal, procedural, financial, or relat-
ed to perceived quality.
Geographical barriers to services and facilities are
especially important, but not exclusively so, for those
in remote areas. Screening facilities were sometimes in
inconvenient locations (A1–A3), involving long travel
distances (A2–A4) and posing transportation difficul-
ties (A1, A2, A5–A8). Temporal barriers include incon-
venient appointment times (A2, A5, A9), long waits
before appointments were available (A1, A5), unsuit-
able appointment times (A3, A10) and waiting room
delays (A5, A11). Delay in receiving results may reduce
participation in subsequent screening or intervention
rounds (A5, A12). Procedural barriers relate to prob-
lems sending screening invitations (A1, A2), limited
Table 1. Summary of included systematic review characteristics.
Number of reviews (n¼ 90)
(English full text only, n¼ 75a)
Publication type All included publications 90 (0a)
Journal article or report in English 75 (75)
Foreign language article 5 (0)
Conference poster or presentation 10 (0)
Outcome Barriers to effective screening only 14 (10)
Facilitators to effective screening only 54 (44)
Both barriers and facilitators 22 (21)
Population (can include 1–3 types) Breast cancer screening 48 (42)
Cervical cancer screening 45 (37)
Colorectal cancer screening 50 (42)





Subgroups included in review
(if appropriate)
Racial/ethnic/immigrant group 28 (23)
Socioeconomic group 1 (1)
Age subgroup 4 (4)
Africa/Asia/low-income country 2 (1)
USA only selection criteria 29 (25)
aThis is the number of systematic reviews with full texts in English.
Figure 3. Barriers or facilitators from the included systematic reviews organized within the first conceptual framework.
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access to primary care (A11, A13) and a variety of
organizational barriers (A4, A10, A13–A15) including
cumbersome administrative processes (A12, A16).
Financial barriers featured in many systematic reviews,
especially where many in the target population lacked
health insurance or other forms of coverage (A6, A9,
A11, A13, A17–A20) or among those whose insurance
excludes coverage of screening (A1, A2, A6, A7, A11,
A13, A14, A17, A21, A22). Some reviews also identi-
fied financial constraints affecting providers (A4, A11,
A13, A23, A24), including the cost of screening tests
(A1, A2, A7, A9, A11, A15), which have implications
for the ability to deliver services – for example, where
constraints affect the ability to recruit and retain staff.
Perceptions of quality also matter (A1, A25), indicated
by objective measures of screening test performance
(A1) or subjective patient experiences (A1, A3, A25).
Only two reviews considered inappropriate screen-
ing due to overuse (A26, A27), which is most often
associated with opportunistic screening, although sev-
eral reviews did highlight features of health systems
that made it difficult to implement organized
population-based screening programmes in place of
opportunistic screening (A18, A28–A31).
In general, these reviews did not take a health sys-
tems perspective – in other words, they did not seek
explanations for the reported barriers in the design of
the health systems in which they were embedded.
However, the findings do suggest weaknesses in rela-
tion to all the inputs to health systems and their
Figure 4. Health system, capability and intention barriers or facilitators within the second conceptual framework.
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building blocks, in particular leadership and gover-
nance, but also service delivery, workforce and infor-
mation systems.
Capability barriers. Only a few reviews examined the
knowledge of healthcare providers (A11, A13, A32).
Instead, most of the available evidence related to the
capability of those being screened, with many studies
identifying lack of awareness of either the rationale for
screening or how to be screened (A2, A4, A8, A9, A11,
A13, A15, A17, A27, A32–A35).
Intention barriers. Multiple reviews identified a failure by
providers to recommend screening (A2, A4, A8, A9,
A11–A13, A17, A19). Some described this as negli-
gence (A32), while others attributed it to a lack of
awareness of the need for screening (A1, A2), particu-
larly for older adults, suggesting an implicit ageism
(A21). Several pointed to inadequate communication
between clinicians, providers and eligible individuals
(A4, A11, A15, A18) but also, and arguably of greater
concern, the spread of misinformation among the lay
public (A1). These findings, and those relating to capa-
bilities, point to weaknesses in leadership and gover-
nance, in particular poor recognition of the need to
understand public knowledge and perceptions and to
put in place measures to address knowledge gaps and
misconceptions.
Whilst this umbrella review explicitly excluded non-
health system barriers specific to individuals or partic-
ular subgroups and cultures – for example, barriers
related to knowledge, attitudes and practices among a
target population – it was notable that these issues
dominated many of the included reviews. These factors
affecting informed participation, or intention to partic-
ipate, are therefore summarized in the online supple-
mentary information (Appendix 6). These factors also
have implications for the leadership and governance of
health systems, highlighting the requirement to put in
place systems to identify unmet need and facilitate
equitable uptake.
The impact of health system barriers versus other barriers.
Assessing the impact of barriers was challenging as
most of the included systematic reviews reporting bar-
riers (24 of 36 reviews) included studies using a variety
of methods, not all of which could quantify impact.
Those that focused on particular study designs included
qualitative (four reviews), observational (one review),
quantitative (three reviews), and interventional studies
(including randomized controlled trials and comparative
studies) (four reviews). Hence, quantitative syntheses
evaluating the impact of barriers were limited. Only
the review of observational studies calculated effect
sizes for different factors affecting compliance (A32).
Of the seven reviews including quantitative and
interventional studies, only one described the most fre-
quently cited barriers (A21), while another counted the
number of studies showing significant association
between specific factors and screening uptake (A36).
Ten of the reviews that included mixed study designs
reported the number identifying each barrier, a very
indirect measure of importance. Otherwise, the impor-
tance of barriers can only be inferred from the narra-
tive syntheses of results of included studies and author
conclusions (see supplementary information).
Once again, most of the reviews focused on the con-
sequences of weaknesses in screening programmes
rather than causes related to the health system.
Thus, many reviews sought to understand and provide
reasons for non-participation, including in specific pop-
ulation groups (Korean Americans, Hmong Americans,
African Americans, Arabic women, Latinas) or in par-
ticular countries (Asia, Africa). In general, the barriers
identified as most important in the narrative reviews
reflect those with most supporting evidence (Figure 3),
with most attention paid to characteristics of the target
population rather than the system itself. Thus, the most
important barriers identified were knowledge/education
(capability barriers) and beliefs and values (intention
barriers) of the population. Next in importance were
financing/access barriers, including characteristics of
the health workforce (training and knowledge). Service
delivery barriers (infrastructure and supplies) were cited
to a lesser extent.
These findings point to a failure of much of the lit-
erature on screening to look upstream at the health
system characteristics that contribute to uptake by
the target population or to use a health systems frame-
work to analyse or interpret findings.
Ways to overcome barriers
Health system facilitators. Some of the most frequently
cited interventions evaluated as means to overcome
health system barriers involved specific practical meas-
ures rather than wider changes to health systems (such
wider changes might include new financing models,
professional roles or settings for service delivery).
Thus, many examined measures to improve screening
invitations (A37–A39), with the aim of increasing
uptake (A1, A2, A5, A9). Examples included having
letters (A37–A39) endorsed by a physician (A7, A40–
A42), personalized (A7, A43), accompanied by a phone
call (A37) or linked to special events promoting screen-
ing (A44). In addition, reminder letters and follow-up
phone calls to those invited (A10, A16, A18, A23, A28,
A30, A37, A40–A42, A45–A49) and reminders to
physicians (A40, A47, A50–A53) were also frequently
mentioned as facilitators. These reminders could be
6 Journal of Health Services Research & Policy 0(0)
computer-generated (A50), part of a recall system
(A16), chart-based (A53) or paper-based (requiring
responses) (A50).
Some interventions that did take a health system
approach addressed the service delivery building
block. Examples included: seeking to reduce geograph-
ic barriers to screening (including reducing distance
needed to travel and increasing the number of facilities
per person or in an area) (A54); providing assistance
with transportation (A7, A10, A55) or free transport
(A42); organizing clinic-based outreach services to
deliver screening nearer areas with low participation
(A56); offering alternative screening sites (A10) or
introducing mobile screening units (A57, A58). Other
aspects of service delivery examined included proce-
dures. Improvements in this regard included having
scheduled appointment times (as opposed to open
appointments, where the onus is on the recipient of
the invitation to make their own appointment) (A41),
flexible appointment times (for example, offering an
option to change to out-of-hours or to meet individual
needs) (A12, A46), more convenient out-of-hours
appointments (A10), measures to decrease waiting
times (A1, A25) and assistance for individuals to help
schedule appointments (A45, A55, A58).
A few interventions addressed the health workforce,
for example, employing staff of the same gender or
minority group (A3–A5, A20). Others transferred
roles to the person being screened, for example, with
self-sampling by post (A31, A40, A41, A48, A59–A61)
where technically possible (for example, self-sampling
for colon and cervical cancer screening).
Two interventions addressed health system financ-
ing, in terms of increasing insurance coverage (A17,
A55). However, most that sought to overcome financial
barriers looked at more targeted approaches (A16,
A32, A53, A62), including providing monetary incen-
tives (A10, A30) or vouchers, or otherwise reducing
out-of-pocket costs (A1, A7, A10, A47, A48, A57).
Human resource strategies featured in a few reviews,
including task shifting, using nurse or community spe-
cialists (A10, A12, A30, A47, A49, A63, A64), screen-
ing in the community setting (lay or outreach workers)
(A28, A42, A49, A56, A58, A65) and involving primary
care workers (A8, A39, A43, A45, A51). The concepts
of ‘patient navigation’ (A29, A42, A45, A52, A55) and
aiding patients to make informed decisions (A66–A68)
were evaluated in several reviews.
Capability facilitators. Some studies considered methods
for facilitating improvement in provider capabilities.
Ways of overcoming knowledge and skill barriers
among providers included cascading of guidelines
(A69), education and training (A31, A58) and measures
to increase the extent to which providers recommend
screening (A8, A24, A32, A42, A70, A71). A few stud-
ies examined measures to enhance the quality of screen-
ing, including improved training of those conducting
screening tests (A1, A10, A12, A25), double reading
of samples (A72, A73), audit and feedback (A47).
However, most reviews focused on measures to
improve uptake by those in target populations (A29,
A56, A74), such as: one-to-one education (A10, A16,
A23, A42, A48); mailed educational material (A18,
A31, A37, A42); face-to-face or phone communication
(A29, A31, A33, A52, A66, A74–A76); counselling
(A18, A31, A38, A42, A63, A66, A67, A75–A77); edu-
cation delivered by lay health workers (A31, A42, A57,
A75, A76); multi-media information (A47, A66, A67,
A76); print material (A67, A76); in-clinic education
(A31); audio education materials (A67); personalized
materials (A7, A29, A33); tailored information (A66,
A76); small group education (A10, A16, A42, A48,
A77); community-based education (A28, A58, A66);
education delivered by media (A28, A42); targeted
media (A10, A16, A23, A77) and mass media (A10,
A16, A56).
Intention facilitators. Measures to motivate providers
inevitably addressed the health workforce building
block. Examples included improving communication
between primary care and other care providers (A5)
and better mechanisms to enable coordination among
clinicians, public health, cultural and religious organi-
zations, advocacy and community groups (A78).
As one study noted, the time and cost constraints
involved in such measures need to be recognized (A32).
Again, however, most measures to improve motiva-
tion were focused on the target populations, including
the linguistic (A45, A55), cultural (A47, A49, A53, A55,
A58, A1, A12), socioeconomic (A62), cognitive (A49)
and other characteristics (A33, A53, A62) of individuals.
Effectiveness of interventions to overcome barriers
The systematic reviews reporting facilitators included
studies with a range of methodologies, but few summa-
rized quantitative data or sought to establish causality.
Forty-one reviews provided some kind of synthesis, of
which 14 presented the number of studies reporting a
positive effect. The lack of standardization across the
reviews – regarding the interventions tested, reported
outcomes, different characteristics of the target popu-
lations and differences in the healthcare organization –
limited the synthesis of results. There is also likely to be
overlap between the reviews of similar interventions,
even though each of the systematic reviews analysed
and reported the results differently. Some reviews
reported factors positively influencing screening
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uptake without measuring effectiveness (A4, A36, A55,
A78, A79).
As shown in Figure 3, much of the available evi-
dence (focusing on systematic reviews that provide a
collated summary of results rather than a report of
individual studies) measuring impact on effectiveness
relates to one of three measures, each directed at indi-
viduals in the target populations. These are educational
interventions (overcoming capability and intention bar-
riers) (A23, A29, A30, A36–A38, A44, A45, A48, A49,
A56, A57, A66–A68, A74, A80–A83), invitation letters
and reminders (A16, A18, A23, A29, A30, A36–A41,
A43, A48, A49, A80, A81) (to a lesser extent, to pro-
viders and healthcare professionals (A36, A50, A51))
and measures to improve access to appointments
(enabling access to the health system) (A41).
The evidence is generally supportive of educational
measures (A8, A29, A30, A38, A52), particularly of edu-
cation delivered via one-to-one sessions (A18, A23, A29,
A48, A74, A81), peers, lay health workers (A49, A56,
A57) or community interventions (A56, A65, A66, A84),
telephone (A29, A36, A66, A74), decision aids (A52,
A67, A68, A83), small media (A16, A23, A81) and
mail (A37, A60, A66), although there are some other
areas that require further investigation (A8, A36,
A38). Multi-faceted interventions also found support
(A29, A49, A57, A80). There is less evidence (either
single reviews or mixed results) to support multi-media
(A36, A66), mass media (A74, A81), special events
(A44), mailed/printed materials (A36, A74), patient nav-
igation (A45), personalized risk communication (A36,
A82) or stage-based promotion (A85), home visits
(A36), tailored (A29) and group education (A48, A81).
The evidence is positively supportive of invitation let-
ters (A36–A39), including those with general practitioner
involvement (A39, A41) (except cervical (A40) or multi-
ple screening examinations (A37)) and/or personalized
letters (A43) or telephone invitation (A36, A37), client
reminders (A16, A18, A23, A30, A36, A37, A40, A41,
A48, A49, A81), telephone reminders (A40, A41, A49)
and physician reminders (A36, A40, A50, A51).
Scheduled appointments (A36, A41) and self-sampling/
mailed outreach are effective (A40, A41, A59, A60, A86).
In contrast, there was a paucity of evidence on measures
to overcome structural health system barriers, such as
removal of financial, geographical or other barriers.
Organized cancer screening programmes and
other arrangements
The inclusion criteria accepted any systematic reviews
that included population-based screening in the popu-
lation at average risk and did not differentiate between
organized programmes (where invitations are dis-
patched to all those eligible, with uptake and outcomes
monitored at a national or regional level) and other
approaches, such as opportunistic screening or screen-
ing at regular health check-ups. However, these
approaches are quite different in their mode of opera-
tion and effectiveness. In general, population-based
organized programmes are more effective than oppor-
tunistic screening in obtaining higher uptake (A39,
A41) and in reducing disparities in the access to screen-
ing (A39). Thus, we examined the extent to which they
are differentiated in the reviews.
Of the 90 included systematic reviews, the vast
majority did not define ‘screening’ in terms of orga-
nized versus other screening arrangements. Only two
reviews, from Italy and the UK, specified ‘organized’
screening programmes (A3, A41). The word ‘pro-
gramme’ was interpreted in various ways. Systematic
reviews by authors from Europe tend to use it in the
sense of organized programmes (A36, A39, A72),
although it was not always clearly defined (A38),
using terms such as ‘community’ (A37, A38), ‘average
risk’ (A22) or ‘mass screening’ (A40, A51). The type of
programme was also not specified in an Australian
review (A4). In the USA, programmes include
community-based interventions to promote uptake of
screening (A56, A58, A66).
Discussion
Summary of evidence
This review identified numerous barriers and facilita-
tors to effective screening for breast, cervical and colo-
rectal cancer. The literature shows that all three cancer
sites have been the subject of studies, with no one cat-
egory particularly dominating. More systematic
reviews examined facilitators than barriers. The overall
quality of the included systematic reviews was good,
although it was difficult to fully assess quality using
the AMSTAR scoring mechanism given the broad
range of review types included, particularly qualitative
reviews.
Although we were interested primarily in character-
istics of health systems that impeded or facilitated
effective screening programmes, and particularly
things that could be done to improve the situation, it
soon became clear that the literature is dominated by
research on the decision by individuals to undergo
screening. Barriers associated with characteristics of
the health system were frequently cited, including geo-
graphical, temporal and informational barriers.
However, responses were largely confined to specific
interventions to deal with particular problems, with
little attention paid to health system changes that
might overcome them. Such changes might include,
for example, new ways of paying for services, reducing
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costs on the individual or even paying them to attend,
as with conditional cash transfers, or new approaches
to professional regulation that might support
task shifting.
The majority of evidence was from the USA, where
there are few organized population-based screening
programmes, unlike in many European countries.
Instead, target groups in the USA are mainly defined
in terms of membership of a specific health insurance
plan or the lack of insurance coverage. There was very
little evidence on how health systems might promote
equitable access to screening. We do know that orga-
nized, rather than opportunistic screening programmes
are more effective in this respect,19,20 but it is important
to consider not just the screening process but the entire
pathway from invitation to eventual treatment, if
needed.21 Importantly, few systematic reviews differen-
tiated studies undertaken within organized and oppor-
tunistic screening activities, although as one review has
noted, even when differentiated, there is often a lack of
clarity about the meaning of the term ‘organized’ in the
context of cancer screening.22
Limitations
This review is potentially subject to English language
and other publication bias. Whilst quality and report-
ing standards were generally good, some information
was missing, particularly for conference posters and
presentations. Moreover, reporting styles varied
among reviews. The scope of this review did not
include consideration of the impact of personal or cul-
tural beliefs. These are important factors that need to
be explored in depth using appropriate psychological
or sociological methods. Due to the heterogeneous and
qualitative nature of much of the included evidence,
quantitative synthesis and statistical testing was not
feasible. There is insufficient space within this paper
to fully evaluate the effectiveness of each of the inter-
ventions included in the systematic reviews, given the
large number and diversity of studies, populations,
interventions and outcomes evaluated. This overview
did not consider the impact on equity of access or
cost effectiveness of facilitators to screening, although
this would be important in considering the sustainabil-
ity of interventions to improve screening.20
Implications
While the present review brings together evidence on
barriers to effective screening programmes, there is a
need for much more research on the complementary
activities required to maximize health gain, including
how to ensure that the appropriate people are invited
for screening, how to reduce opportunistic screening
and how to improve follow-up and monitoring of
people once they have been screened.
Conclusion
Whilst many systematic reviews have been conducted
on the topic of barriers and facilitators to cancer
screening, much of the evidence is focused on the
USA and on individual participation. There is a need
for further research into barriers and facilitators from a
health systems perspective, all along the pathway from
offering screening through to follow-up interventions
for those that need them.
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